Berliner Boersenzeitung - Pharma giants to pay $590 mn to US Native Americans over opioids

EUR -
AED 3.995362
AFN 72.879605
ALL 98.279106
AMD 421.060772
ANG 1.961671
AOA 992.037372
ARS 1079.883898
AUD 1.650502
AWG 1.957968
AZN 1.848211
BAM 1.9506
BBD 2.197642
BDT 130.07325
BGN 1.956076
BHD 0.409923
BIF 3149.065907
BMD 1.08776
BND 1.432221
BOB 7.538113
BRL 6.300416
BSD 1.088399
BTN 91.544784
BWP 14.493762
BYN 3.562202
BYR 21320.10079
BZD 2.194012
CAD 1.511932
CDF 3093.590087
CHF 0.940059
CLF 0.037622
CLP 1038.115053
CNY 7.729194
CNH 7.744086
COP 4802.461479
CRC 558.610853
CUC 1.08776
CUP 28.825646
CVE 110.570286
CZK 25.337523
DJF 193.316613
DKK 7.457728
DOP 65.755289
DZD 144.924474
EGP 53.362292
ERN 16.316404
ETB 131.730194
FJD 2.475688
FKP 0.83232
GBP 0.839365
GEL 2.975022
GGP 0.83232
GHS 17.795417
GIP 0.83232
GMD 77.774428
GNF 9387.370605
GTQ 8.409582
GYD 227.918699
HKD 8.456411
HNL 27.270436
HRK 7.493613
HTG 143.238155
HUF 408.073167
IDR 17156.80723
ILS 4.079737
IMP 0.83232
INR 91.526159
IQD 1424.96592
IRR 45800.145229
ISK 148.903481
JEP 0.83232
JMD 171.981531
JOD 0.771335
JPY 165.659408
KES 140.320912
KGS 93.328602
KHR 4432.622841
KMF 492.21194
KPW 978.983975
KRW 1499.504725
KWD 0.33341
KYD 0.907107
KZT 531.852186
LAK 23865.459643
LBP 97463.318006
LKR 319.109317
LRD 208.686872
LSL 19.04682
LTL 3.211873
LVL 0.657975
LYD 5.232249
MAD 10.711134
MDL 19.42974
MGA 5020.01397
MKD 61.608784
MMK 3533.002843
MNT 3696.209341
MOP 8.71421
MRU 43.510008
MUR 49.852176
MVR 16.748932
MWK 1887.810848
MXN 21.88318
MYR 4.752392
MZN 69.503294
NAD 19.046414
NGN 1788.049647
NIO 40.002392
NOK 11.962274
NPR 146.471575
NZD 1.820166
OMR 0.418813
PAB 1.088528
PEN 4.098953
PGK 4.361369
PHP 63.556199
PKR 302.234637
PLN 4.358541
PYG 8572.148333
QAR 3.960101
RON 4.975525
RSD 117.015772
RUB 107.688744
RWF 1483.704973
SAR 4.085607
SBD 9.035177
SCR 14.763818
SDG 654.283077
SEK 11.668624
SGD 1.434821
SHP 0.83232
SLE 24.719375
SLL 22809.784965
SOS 621.111205
SRD 37.969403
STD 22514.440879
SVC 9.523612
SYP 2733.030539
SZL 19.046919
THB 36.714631
TJS 11.592317
TMT 3.818038
TND 3.370961
TOP 2.547647
TRY 37.371852
TTD 7.378534
TWD 34.793422
TZS 2927.024714
UAH 45.11385
UGX 3983.381087
USD 1.08776
UYU 45.349108
UZS 13939.647593
VEF 3940468.630106
VES 46.559442
VND 27514.895381
VUV 129.141114
WST 3.047017
XAF 654.230992
XAG 0.032247
XAU 0.0004
XCD 2.939726
XDR 0.817643
XOF 653.199741
XPF 119.331742
YER 271.776542
ZAR 19.035368
ZMK 9791.150456
ZMW 29.197969
ZWL 350.258355
  • RBGPF

    66.4100

    66.41

    +100%

  • SCS

    0.1100

    12.25

    +0.9%

  • CMSC

    0.1100

    24.64

    +0.45%

  • BCC

    0.0500

    134.26

    +0.04%

  • NGG

    0.1900

    64.45

    +0.29%

  • BCE

    -2.9800

    29.12

    -10.23%

  • RELX

    -0.0200

    47.06

    -0.04%

  • JRI

    0.0500

    13.1

    +0.38%

  • CMSD

    0.1103

    24.92

    +0.44%

  • RYCEF

    0.0100

    7.11

    +0.14%

  • RIO

    -0.3200

    65.01

    -0.49%

  • VOD

    -0.0300

    9.32

    -0.32%

  • AZN

    0.0100

    71.43

    +0.01%

  • GSK

    0.0900

    36.97

    +0.24%

  • BP

    0.5000

    29.73

    +1.68%

  • BTI

    0.0400

    35.11

    +0.11%

Pharma giants to pay $590 mn to US Native Americans over opioids
Pharma giants to pay $590 mn to US Native Americans over opioids

Pharma giants to pay $590 mn to US Native Americans over opioids

A group of pharmaceutical companies and distributors agreed to pay $590 million to settle lawsuits connected to opioid addiction among Native American tribes, according to a US court filing released Tuesday.

Text size:

The agreement is the latest amid a deluge of litigation spawned by the US opioid crisis, which has claimed more than 500,000 lives over the last 20 years and ensnared some of the largest firms in the world of American medicine.

The companies involved in the latest agreement include Johnson & Johnson and McKesson, according to a filing in an Ohio federal court by a committee of plaintiffs in the case.

Native Americans have "suffered some of the worst consequences of the opioid epidemic of any population in the United States," according to the filing from the Plaintiffs' Tribal Leadership Committee, which cited per-capita death rates compared with other ethnic groups.

"The burden of paying these increased costs has diverted scarce funds from other needs and has imposed severe financial burdens on the tribal plaintiffs."

Johnson & Johnson, McKesson and the other two companies in the accord -- AmerisourceBergen and Cardinal Health -- have previously agreed to a $26 billion global settlement on opioid cases.

J&J said Tuesday the $150 million it agreed to pay in the Native American case has been deducted from what it owes in the global settlement.

"This settlement is not an admission of any liability or wrongdoing and the company will continue to defend against any litigation that the final agreement does not resolve," the company said.

It was unclear if the other companies would take what they owe under the latest agreement from the global settlement.

- 'Measure of justice' -

Robins Kaplan, a law firm negotiating on the behalf of the plaintiffs, said in a statement the agreement must still be approved by the Native American tribes, which are pursuing other claims regarding opioids.

"This initial settlement for tribes in the national opioid litigation is a crucial first step in delivering some measure of justice to the tribes and reservation communities across the United States that have been ground zero for the opioid epidemic," Tara Sutton, an attorney at the firm who negotiated on behalf of the Native Americans.

Douglas Yankton, chairman of the North Dakota-based Spirit Lake Nation, said the money from the settlement would "help fund crucial, on-reservation, culturally appropriate opioid treatment services."

All tribes recognized by the US government, 574 in all, will be able to participate in the agreement, even if they have not filed lawsuits.

The settlement is separate from a prior agreement that resulted in $75 million in payments to the Cherokee Nation from three distribution companies, including McKesson.

Many of the lawsuits regarding the opioid crisis have centered on Purdue Pharma, the manufacturer of OxyContin, a highly addictive prescription painkiller blamed for causing a spike in addiction.

A judge in December overturned the company's bankruptcy plan because it provided some immunity for the owners of the company in exchange for a $4.5 billion payout to victims of the opioid crisis.

The litigation wave has also swamped pharmacies owned by Walmart, Walgreens and CVS, which a jury found in November bear responsibility for the opioid crisis in two counties in Ohio.

(O.Joost--BBZ)